Building Your Child's CMD Care Team
At a Glance
Children with congenital muscular dystrophy require a multidisciplinary care team led by a neuromuscular specialist. Essential members include pulmonologists, cardiologists, and therapists who coordinate treatments, monitor disease progression, and support your child's overall quality of life.
Navigating the medical world after a CMD diagnosis can feel like learning a new language. Because CMD affects multiple systems, your child will need a “medical home”—a multidisciplinary clinic where various specialists work together to provide coordinated care [1]. Organizing your team and your records early is the best way to ensure your child receives the highest standard of care.
Your CMD “Care Team” Roster
A comprehensive team should include experts who understand how muscle disease specifically impacts their area of the body. Key specialists include:
- Neuromuscular Pediatrician/Neurologist: The “quarterback” of the team who coordinates diagnosis, monitors muscle progression, and stays updated on clinical trials [1][2].
- Pulmonologist (Breathing Specialist): Monitors lung strength and sleep health. They are essential for setting up “cough assist” machines or nighttime breathing support (BiPAP) [3][4].
- Cardiologist (Heart Specialist): Provides baseline and regular screenings (EKGs/Echos) to watch for heart muscle weakness or rhythm issues, which are critical in subtypes like LMNA-related CMD [5][6].
- Orthopedic Surgeon: Monitors the spine for scoliosis and joints for contractures (stiffness) [7].
- Rehabilitation Team: Includes Physical Therapists (PT) for mobility, Occupational Therapists (OT) for daily activities, and Speech/Language Pathologists (SLP) for feeding and communication [8][9].
- Registered Dietitian: Ensures your child is getting proper nutrition and managing weight, as muscle tone can affect how many calories the body needs [10].
Preparing for the First Visit
Specialist clinics often see many patients, so arriving prepared ensures your time is used effectively. Bring a folder (or a digital drive) containing the following “artifacts”:
- The Genetic Test Report: The full lab report for the Whole-Exome Sequencing (WES) or CMD panel is the most important document you own [11].
- Imaging Discs: Don’t just bring the written report; bring the actual digital images (on a CD or USB) of any brain or muscle MRIs [12][13].
- Growth Charts: A record of your child’s height and weight over time helps the team see if they are meeting nutritional goals [2].
- Therapy Reports: Recent evaluations from PT, OT, or early intervention services.
Evaluating Your Specialist
Since CMD is rare, not every neurologist is an expert in every subtype. It is okay to “vet” your doctor to ensure they have the right experience. A good specialist will welcome these questions:
- “Are you familiar with the specific monitoring needs for my child’s gene?” (For example, asking about the unique cardiac risks in LMNA or the rigid spine in SELENON) [5][14].
- “Does your clinic follow the ENMC (European Neuromuscular Centre) consensus guidelines?” This shows you are looking for evidence-based care [1].
- “How does your office handle communication between specialists?” Multidisciplinary care only works if the heart doctor and the lung doctor are talking to each other [15].
- “How does your clinic assist with providing medical documentation for school supports like IEPs?” Because physical accommodations are critical for academic success, a proactive clinic will help document these needs early.
By building a specialized team and maintaining organized records, you become the most effective advocate for your child’s health and quality of life [8].
Common questions in this guide
Which doctors should be on my child's CMD care team?
What should I bring to my child's first neuromuscular clinic visit?
Why does my child with congenital muscular dystrophy need a cardiologist?
How can a multidisciplinary CMD clinic help with my child's schooling?
What questions should I ask when evaluating a new CMD specialist?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How many other patients with this specific genetic subtype of CMD have you treated or followed in this clinic?
- 2.Are you familiar with the most recent ENMC consensus guidelines for my child’s specific subtype?
- 3.Does this clinic have a dedicated care coordinator who can help sync my child's appointments with different specialists (cardiology, pulmonology, etc.)?
- 4.How does your clinic assist with providing medical documentation for school supports, such as an Individualized Education Program (IEP)?
- 5.Can you explain how this center handles transitions between pediatric and adult neuromuscular care in the long term?
- 6.Does your team participate in any natural history studies or registries for my child's specific gene?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
283rd ENMC international workshop: Establishing expert care recommendations for LAMA2-RD: A prototype for the development of congenital muscular dystrophy subtype-specific care guidelines. Hoofddorp, The Netherlands, January 17th-19th 2025.
Zambon AA, Klein A, Sarkozy A, et al.
Neuromuscular disorders : NMD 2025; (55()):106220 doi:10.1016/j.nmd.2025.106220.
PMID: 41106238 - 2
Muscular Dystrophy: A Retrospective Evaluation of 15 Cases.
Güngör O, Dilber C
Sisli Etfal Hastanesi tip bulteni 2018; (52(1)):47-50 doi:10.14744/SEMB.2017.53496.
PMID: 32595371 - 3
Dropped head congenital muscular dystrophy caused by de novo mutations in LMNA.
Karaoglu P, Quizon N, Pergande M, et al.
Brain & development 2017; (39(4)):361-364 doi:10.1016/j.braindev.2016.11.002.
PMID: 27876398 - 4
International retrospective natural history study of LMNA-related congenital muscular dystrophy.
Ben Yaou R, Yun P, Dabaj I, et al.
Brain communications 2021; (3(3)):fcab075 doi:10.1093/braincomms/fcab075.
PMID: 34240052 - 5
The most severe form of LMNA-associated congenital muscular dystrophy.
Murofushi Y, Hayakawa I, Abe Y, et al.
Brain & development 2022; (44(9)):650-654 doi:10.1016/j.braindev.2022.05.006.
PMID: 35729056 - 6
Importance of early diagnosis in LMNA-related muscular dystrophy for cardiac surveillance.
Choi SA, Cho A, Kim SY, et al.
Muscle & nerve 2019; (60(6)):668-672 doi:10.1002/mus.26700.
PMID: 31498906 - 7
Operative treatment of severe scoliosis and pelvic obliquity in patients with spinal muscular atrophy: assessment of outcomes and complications.
Sun H, Huang Y, Dong Y, et al.
Orphanet journal of rare diseases 2025; (20(1)):174 doi:10.1186/s13023-025-03682-8.
PMID: 40217273 - 8
Spatial proteomics reveals recombinant human laminin-111 restores adhesion signaling to laminin-α2-deficient muscle.
Hermann HJ, Wuebbles RD, Dagda M, et al.
JCI insight 2025; (10(22)).
PMID: 41118381 - 9
A 17-Year-Old With Becker Muscular Dystrophy and Unusual Polysomnography Findings.
Paul GR, Khayat RN, Kotha K, et al.
Chest 2021; (159(1)):e19-e23 doi:10.1016/j.chest.2020.08.2057.
PMID: 33422235 - 10
Percutaneous Endoscopic Gastrostomy and Nutritional Interventions by the Pediatric Nutritional Support Team Improve the Nutritional Status of Neurologically Impaired Children.
Suh CR, Kim W, Eun BL, Shim JO
Journal of clinical medicine 2020; (9(10)) doi:10.3390/jcm9103295.
PMID: 33066538 - 11
Exome sequencing in the pediatric neuromuscular clinic leads to more frequent diagnosis of both neuromuscular and neurodevelopmental conditions.
Meyer AP, Ma J, Brock G, et al.
Muscle & nerve 2023; (68(6)):833-840 doi:10.1002/mus.27976.
PMID: 37789688 - 12
New diagnostic and therapeutic modalities in neuromuscular disorders in children.
Chikkannaiah M, Reyes I
Current problems in pediatric and adolescent health care 2021; (51(7)):101033 doi:10.1016/j.cppeds.2021.101033.
PMID: 34281812 - 13
Muscle MRI and functional outcome measures in Becker muscular dystrophy.
Barp A, Bello L, Caumo L, et al.
Scientific reports 2017; (7(1)):16060 doi:10.1038/s41598-017-16170-2.
PMID: 29167533 - 14
A novel mutation in SEPN1 causing rigid spine muscular dystrophy 1: a Case report.
Ziyaee F, Shorafa E, Dastsooz H, et al.
BMC medical genetics 2019; (20(1)):13 doi:10.1186/s12881-018-0743-1.
PMID: 30642275 - 15
The Expanding Spectrum of Dystrophinopathies: HyperCKemia to Manifest Female Carriers.
Suthar R, Kesavan S, Sharawat IK, et al.
Journal of pediatric neurosciences 2021; (16(3)):206-211 doi:10.4103/jpn.JPN_89_20.
PMID: 36160614
This page provides general information about building a care team for congenital muscular dystrophy. It is for educational purposes only and does not replace personalized medical advice from your child's healthcare providers.
Get notified when new evidence is published on Congenital muscular dystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.